Cargando…
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patient...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240452/ https://www.ncbi.nlm.nih.gov/pubmed/35768102 http://dx.doi.org/10.1136/bmjopen-2021-056371 |
_version_ | 1784737557914845184 |
---|---|
author | Alhaddad, Fatemah Abdulkareem, Ali Alsharrah, Danah Alkandari, Abdullah Bin-Hasan, Saadoun Al-Ahmad, Mona Al Hashemi, Hashem Alghounaim, Mohammad |
author_facet | Alhaddad, Fatemah Abdulkareem, Ali Alsharrah, Danah Alkandari, Abdullah Bin-Hasan, Saadoun Al-Ahmad, Mona Al Hashemi, Hashem Alghounaim, Mohammad |
author_sort | Alhaddad, Fatemah |
collection | PubMed |
description | OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait. PARTICIPANTS: The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals. RESULTS: Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes. CONCLUSION: SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection. |
format | Online Article Text |
id | pubmed-9240452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-92404522022-06-30 Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait Alhaddad, Fatemah Abdulkareem, Ali Alsharrah, Danah Alkandari, Abdullah Bin-Hasan, Saadoun Al-Ahmad, Mona Al Hashemi, Hashem Alghounaim, Mohammad BMJ Open Infectious Diseases OBJECTIVE: Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children. DESIGN: This is a population-level retrospective cohort study. SETTING: Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait. PARTICIPANTS: The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals. RESULTS: Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes. CONCLUSION: SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection. BMJ Publishing Group 2022-06-27 /pmc/articles/PMC9240452/ /pubmed/35768102 http://dx.doi.org/10.1136/bmjopen-2021-056371 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infectious Diseases Alhaddad, Fatemah Abdulkareem, Ali Alsharrah, Danah Alkandari, Abdullah Bin-Hasan, Saadoun Al-Ahmad, Mona Al Hashemi, Hashem Alghounaim, Mohammad Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title | Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title_full | Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title_fullStr | Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title_full_unstemmed | Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title_short | Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait |
title_sort | incidence of sars-cov-2 reinfection in a paediatric cohort in kuwait |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240452/ https://www.ncbi.nlm.nih.gov/pubmed/35768102 http://dx.doi.org/10.1136/bmjopen-2021-056371 |
work_keys_str_mv | AT alhaddadfatemah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT abdulkareemali incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT alsharrahdanah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT alkandariabdullah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT binhasansaadoun incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT alahmadmona incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT alhashemihashem incidenceofsarscov2reinfectioninapaediatriccohortinkuwait AT alghounaimmohammad incidenceofsarscov2reinfectioninapaediatriccohortinkuwait |